Table 2.
CT83 expression with patient characters of atrophic gastritis
| Clinicopathological parameters | Categories | Total | CT83 expression | |
|---|---|---|---|---|
| (n=115) | Positive | Negative | ||
| Age (average ± SD) | - | 66.1 ± 12.0 | 67.4 ± 8.6 | 66.1 ± 12.2 |
| Gender | Male | 64 (56%) | 5 (8%) | 59 (92%) |
| Female | 51 (44%) | 3 (6%) | 48 (94%) | |
| Hp infection | Positive | 69 (60%) | 8 (12%) | 61 (88%) |
| Negative | 46(40%) | 0 (0%) | 46 (100%) | |
| Atrophic severity | High (O1-O3) | 65 (57%) | 6 (9%) | 59 (91%) |
| Low (C1-C3) | 36 (31%) | 2 (6%) | 34 (94%) | |
| Not recorded | 14 (12%) | 0 (0%) | 14 (100%) | |
| CT83 expression | Positive | 8 (7%) | - | - |
| Negative | 107 (93%) | - | - | |
Values are presented as number (%) or mean ± standard deviation.
CT83; Kita-kyushu lung cancer antigen-1, Hp; Helicobacter pylori.
Atrophic severity was classified as high and low with O1 to O3 and C1 to C3 of Kimura-Takemoto classification, respectively.